Opportunity in distress

While Delhi continues to grapple with the outbreak of dengue and chikungunya, it has triggered an unexpected buying opportunity in the stock market. Some brokerages have upped their earnings expectations and price target on Delhi-based Dr Lal PathLabs, which listed earlier this year. According to some analysts, the disease outbreak will give a boost to the business of the pathology chain and help improve profit margins.